CSF2 and myeloid sarcoma: B cells in MS patients have aberrant cytokine profiles, typically exhibiting increased ability to produce pro-inflammatory cytokines, such as IL-6 and GM-CSF, and decreased production of anti-inflammatory cytokines, such as IL-10 [28,39].